T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$8.01B |
| 2 |
Amazon
AMZN
|
+$5.64B |
| 3 |
Danaher
DHR
|
+$4.2B |
| 4 |
Gilead Sciences
GILD
|
+$4.09B |
| 5 |
JPMorgan Chase
JPM
|
+$4.03B |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 13.97% |
| 3 | Consumer Discretionary | 13.35% |
| 4 | Industrials | 11.58% |
| 5 | Technology | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDS.B
226
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $437M | 0.12% |
+6,594,181
| New | +$450M |
|
|
ONXX
227
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $429M | 0.11% |
+4,937,894
| New | +$455M |
|
228
IDEX
IEX
$17.5B
| $428M | 0.11% |
+7,962,380
| New | +$424M |
|
229
Campbell Soup
CPB
$6.78B
| $427M | 0.11% |
+9,533,833
| New | +$433M |
|
230
Willis Towers Watson
WTW
$31.8B
| $426M | 0.11% |
+3,940,996
| New | +$417M |
|
|
LM
231
DELISTED
Legg Mason, Inc.
LM
| $422M | 0.11% |
+13,604,712
| New | +$445M |
|
232
Groupon
GRPN
$889M
| $421M | 0.11% |
+2,477,403
| New | +$335M |
|
233
Aptiv
APTV
$10.3B
| $421M | 0.11% |
+8,298,397
| New | +$389M |
|
234
Liberty Global Class A
LBTYA
$3.48B
| $420M | 0.11% |
+13,745,978
| New | +$420M |
|
235
Baxter International
BAX
$14.3B
| $414M | 0.11% |
+11,011,104
| New | +$422M |
|
236
Motorola Solutions
MSI
$77.3B
| $407M | 0.11% |
+7,051,498
| New | +$413M |
|
237
Franco-Nevada
FNV
$46.4B
| $403M | 0.11% |
+11,305,633
| New | +$455M |
|
238
Viavi Solutions
VIAV
$9.47B
| $401M | 0.11% |
+49,021,322
| New | +$379M |
|
239
SLM Corp
SLM
$5.11B
| $399M | 0.11% |
+48,781,641
| New | +$381M |
|
|
AET
240
DELISTED
Aetna Inc
AET
| $397M | 0.11% |
+6,246,778
| New | +$367M |
|
|
MHFI
241
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $397M | 0.11% |
+7,456,484
| New | +$400M |
|
|
ATML
242
DELISTED
ATMEL CORP
ATML
| $396M | 0.11% |
+53,871,950
| New | +$380M |
|
243
Colgate-Palmolive
CL
$73.6B
| $389M | 0.1% |
+6,791,096
| New | +$403M |
|
244
Vornado Realty Trust
VNO
$7.24B
| $388M | 0.1% |
+6,404,274
| New | +$396M |
|
245
Vodafone
VOD
$36.7B
| $387M | 0.1% |
+13,199,880
| New | +$394M |
|
|
SE
246
DELISTED
Spectra Energy Corp Wi
SE
| $384M | 0.1% |
+11,135,780
| New | +$351M |
|
247
Macy's
M
$6.45B
| $382M | 0.1% |
+7,956,051
| New | +$369M |
|
248
MSCI
MSCI
$40.8B
| $382M | 0.1% |
+11,471,368
| New | +$387M |
|
249
Amdocs
DOX
$6.1B
| $382M | 0.1% |
+10,287,700
| New | +$367M |
|
250
Equifax
EFX
$21.4B
| $381M | 0.1% |
+6,457,082
| New | +$390M |
|
Similar funds
T. Rowe Price Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for T. Rowe Price Associates, which disclosed 2,429 positions worth $374B. Its ten largest holdings account for 12% of the portfolio.
Its largest position is Alphabet (Google) Class C: 378,851,526 shares worth $8.31B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2013 buy was Alphabet (Google) Class C: 378,851,526 shares worth $8.31B.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $374B portfolio in Q2 2013.
- T. Rowe Price Associates disclosed 2,429 positions in Q2 2013, its first 13F filing on record.
Based on T. Rowe Price Associates's 13F filing for Q2 2013, filed 14 Aug 2013.